期刊文献+

简化的局部枸橼酸抗凝在连续性血液净化中的应用 被引量:9

Application of simplified regional citrate anticoagulation in continuous blood purification
下载PDF
导出
摘要 目的探讨简化的枸橼酸抗凝在连续性血液净化中的应用。方法回顾性分析40例采用枸橼酸抗凝行连续性血液净化治疗患者的临床资料,置换液采用含钙置换液,静脉端无需泵入钙,监测治疗前后患者的凝血功能、肾功能、电解质及滤器使用寿命。结果 40例患者共行连续性血液净化1 316.30 h,滤器平均使用寿命为45.38 h。治疗后外周血尿素、肌酐较治疗前明显下降,差异有统计学意义(P<0.05);治疗后外周血酸碱度、HCO3-较治疗前升高,差异有统计学意义(P<0.05);治疗前后外周血游离钙离子比较差异无统计学意义(P>0.05)。治疗前后血浆凝血酶原时间、活化的部分凝血活酶时间、血浆凝血酶时间及纤维蛋白原等无明显变化,差异无统计学意义(P>0.05)。所有患者无出血事件发生。结论枸橼酸抗凝安全有效,出血风险小,含钙置换液简化了枸橼酸抗凝的流程。 Objective To explore the application of simplified citrate anticoagulation in continuous blood purification. Methods The clinical data of forty patients with citrate anticoagulation in continuous blood purification therapy was analyzed retrospectively. The displacement liquid contained calcium ion, and venous end without pumping calcium. The blood coagulation function, renal function, electrolyte, and useful life of filter were monitored. Results Forty patients underwent continuous blood purification for 1 316.30 hours ,and the average useful life of filter was 45.38 h. Compared with before treatment,the urea and creatinine after treatment decreased(P 〈0.05) ;the pH value and HCOs - increased(P 〈0. 05). There was no statistic difference of periphery dissociation Ca2 + before and after treatment ( P 〉 0.05 ). There was no statistic difference of plasma prothrombin time, activated partial thromboplastin time, blood plasma thrombin time, and fibrinogen before and after treatment (P 〉 0. 05 ). No bleeding events occured. Conclusion The citrate anticoagulation is safe and effective and the risk of bleeding is small. The displacement liquid containing calcium simplifies the citrate anticoagulation process,it is worthy of promotion.
出处 《新乡医学院学报》 CAS 2014年第10期831-833,共3页 Journal of Xinxiang Medical University
关键词 枸橼酸抗凝 血液净化 局部 citric acid anticoagulation blood purification region
  • 相关文献

参考文献12

  • 1Tolwani A J, Wille K M. Anticoagulation for continuous renal re- placement therapy[ J]. Semin Dia ,2009,22 : 141-145.
  • 2Oudemans-van Straaten H M, Bosman R J, Koopmans M, et al. Cit- rate anticoagulation for continuous venovenous hemofihration [ J ]. Crit Care Med ,2009,37 ( 2 ) :545-552.
  • 3Park J S, Kim G H, Kang C M, et aL Regional anticoagulation with citrate is superior to systemic anticoagulation with heparin in criti- cally ill patients undergoing continuous venovenous hemodiafiltra- tion [ J ]. Korean J Intern Med, 2011,26 ( 1 ) : 68-75.
  • 4van de Wetering J, Westendorp R G, van der Hoeven J G, et al. Heparin use in continuous renal replacement procedures:the strug- gle between filter coagulation and patient hemorrhage [ J ]. J Am Soc Nephrol, 1996,7 ( 1 ) : 145-150.
  • 5Martin P Y, Chevrolet J C, Surer P, et al. Anticoagulation in pa- tients treated by continuous venovenous hemofiltration:a retrospec- tive study [ J ]. Am J Kidney Dis, 1994,24 ( 5 ) : 806 -812.
  • 6Gabutti L, Maronc C, Colucci G, et al. Citrate anticoagulation in continuous venovenous hemodiafiltration: a metabolic challenge [ J]. Intensive Care Med ,2002,28 (10) : 1419-1425.
  • 7Morita R W, Johnson R W, Dora R E, et al. Regional anticoagula- tion during hemodialysis using citrate [ J ]. Am J Med Sci, 1961, 242( 1 ) :32-43.
  • 8Mehta R L, McDonald B R, Aguilar M M, el al. Regional citrate an- ticoagulation for continuous arteriovenous hemodialysis in critically ill patients [ J] . Kidney Int, 1990,38 (5) :976-981.
  • 9Tolwani A J, Campbell R C, Schenk M B, et al. Simplified citrate anticoagulatlon for continuous renal replacement therapy [ J ]. Kid- hey lnt,2001,60( 1 ) :370-374.
  • 10Kutsogiannis D J, Mayers I, Chin W D, et al. Regional citrate anti- coagulation in continuous venovenous hemodiafiltration[ J ]. Am J Kidney Dis,2000,35 ( 5 ) :802-811.

同被引文献67

  • 1何圆凤.高危出血患者行局部枸橼酸抗凝血液净化的临床效果观察[J].医学信息(医学与计算机应用),2016,29(25):139-139. 被引量:6
  • 2郭发良,卜会驹,杨秀洁,秦志梅,阎红霞.血细胞分离机行血浆置换在危重病人中的应用研究[J].临床和实验医学杂志,2007,6(6):53-54. 被引量:5
  • 3Oudemans-van Straaten HM, Bosman ILl, Koopmans M, et al. Citrate anti- coagulation for continuous venovenous hemofiltration[J]. Crit Care Med, 2009,37 (2) : 545-552.
  • 4Park JS ,Kim GH ,Kang CM ,et al. Regional anticoagulation withcitrate is superior to systemic anticoagulation with heparin in critically ill patients undergoing continuous venovenous hemodiafiltration [J]. Korean J Intern Med,2011,26( 1 ) : 68-75.
  • 5Moran J,Sun S,Khababa I,et al. A randomized trial comparing gentamicin/ citrate and heparin locks for central venous catheters in maintenance hemodialysis patients[J]. Am J Kidney Dis ,2012,59 (1) :102-107.
  • 6Morgera S, Scholle C, Voss G, et al. Metabolic complications during re- gional citrate anticoagulation in continuous venovenous hemodialysis: single-center experience [J]. Nephron Clin Pratt ,2004,97 (4) : 131-136.
  • 7Dhondt A ,Vanholder R,Tielemans C, et al. Effect of regional citrate an- ticoagulation on leukopenia,complement activation,and expression of leukocyte surface molecules duringhemodialysis with unmodified cellulose membranes[J]. Nephron,2000, 85(4) :334-342.
  • 8Hofbauer R, Moser D, Frass M, et al. Effect of anticoagulation on blood membraueinteractions during hemodialysis[J]. Kidney Int, 1999,56 (4) : 1578-1583.
  • 9王涌,陈香美,孙雪峰,向晶.高容量血液滤过治疗中阿加曲班抗凝剂量的探讨[J].中国危重病急救医学,2009,21(4):240-242. 被引量:5
  • 10郑寅,许钟烨,焦正,朱秋毓,刘骏峰,顾勇,林善锬,郝传明,丁峰.连续性肾脏替代治疗时枸橼酸药物代谢动力学数学模型的构建[J].中华肾脏病杂志,2010,26(6):432-437. 被引量:14

引证文献9

二级引证文献62

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部